PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS

The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100...

Full description

Saved in:
Bibliographic Details
Published inAfrican journal of traditional, complementary, and alternative medicines Vol. 14; no. 2; pp. 25 - 32
Main Authors Huwait, Etimad A, Al-Ghamdi, Maryam A
Format Journal Article
LanguageEnglish
Published Nigeria African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw, and carnitine (20 mg/kg bw, daily. On 7 , 8 , and 9 day, rats in groups (II-V) were injection with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days. Canirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones. Vitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity.
AbstractList Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Materials and Methods: Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily .Group V: Rats were injected with both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7th, 8th, and 9th day, rats in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days. Results: Canirine combined with vitamin E significantly increased coronary flow (CF) (P
BACKGROUNDThe current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats.MATERIALS AND METHODSRats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7th, 8th, and 9th day, rats in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days.RESULTSCanirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones.CONCLUSIONVitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity.
The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol (ISO) in rats. Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily. Group V: Rats were injected with both vitamin E (100 IU/kg bw, and carnitine (20 mg/kg bw, daily. On 7 , 8 , and 9 day, rats in groups (II-V) were injection with ISO (55mg/kg b.w for successive three days). The treatment with carnitine and vitamin E were continuous for 21 days. Canirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis factor (TNF-α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase (p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones. Vitamin E combined with carnitine exerts potential protective effect against MI through suppression of inflammatory mediators and enhancement of antioxidant activity.
Author Huwait, Etimad A
Al-Ghamdi, Maryam A
AuthorAffiliation 3 Vitamin D Pharmacogenomics Research Group, King Abdulaziz University, Jeddah, Saudi Arabia
2 Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia
1 Biochemistry Department, Faculty of science, King Abdulaziz University, Saudi Arabia
AuthorAffiliation_xml – name: 1 Biochemistry Department, Faculty of science, King Abdulaziz University, Saudi Arabia
– name: 2 Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia
– name: 3 Vitamin D Pharmacogenomics Research Group, King Abdulaziz University, Jeddah, Saudi Arabia
Author_xml – sequence: 1
  givenname: Etimad A
  surname: Huwait
  fullname: Huwait, Etimad A
  organization: Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia
– sequence: 2
  givenname: Maryam A
  surname: Al-Ghamdi
  fullname: Al-Ghamdi, Maryam A
  organization: Experimental biochemistry unit, King Fahad Medical Research center (KFMRC), King Abdulaziz University, Saudi Arabia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28573219$$D View this record in MEDLINE/PubMed
BookMark eNpVkUlPwzAQhS0EgrKcuSEfuaS1HWfxBSlK3dZSSVAaQHCxHMeBVG0CSVuJf0-6gODi8WjefDOadw6Oq7oyAFxj1CcYYTRQ85VWy_4G05L06RHoEQc5FkKUHoMewj6zXITdM3DetnOEbB8T7xScEd_xbIJZD9QPSZzyMBVPHCbxlMN4BMMgiUQqIg5nLxFPxuKVD-GzSCfwSaTBvYggh8E4ENEshWIW7wgJj-IpFNHwMezEHWEogrDLR0HSweOo-8IkSGeX4KRQi9ZcHeIFeBzxNJxY03gswmBqaeJ6KytnnqFG267KGHM0VcZXfu5iU-g8sz3CMCW2Mq6bkbzIKNI5wiZ3soJ6xmeM2hfgbs_9WGdLk2tTrRq1kB9NuVTNl6xVKf9XqvJdvtUb6VDqUgd1gNsDoKk_16ZdyWXZarNYqMrU61Zihrobds921mAv1U3dto0pfsdgJHc2yb1NcmeT3Hbc_N3uV__ji_0NfdWKpg
CitedBy_id crossref_primary_10_1016_j_heliyon_2024_e25057
crossref_primary_10_5812_ijhrba_84212
crossref_primary_10_37349_emed_2021_00070
crossref_primary_10_1016_j_biopha_2021_112139
crossref_primary_10_2174_1389557519666190130164334
ContentType Journal Article
Copyright Copyright: © 2017 Afr. J. Traditional Complementary and Alternative Medicines 2017
Copyright_xml – notice: Copyright: © 2017 Afr. J. Traditional Complementary and Alternative Medicines 2017
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.21010/ajtcam.v14i2.4
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2505-0044
EndPage 32
ExternalDocumentID 10_21010_ajtcam_v14i2_4
28573219
Genre Journal Article
GroupedDBID ---
23M
2WC
4JU
53G
5GY
AAFWJ
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CGR
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
GX1
HYE
KWQ
NPM
OK1
P2P
P6G
RBI
RPM
TR2
XSB
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c267t-d97e4ec36ab995c4ae8a8d61efcdb37291423ae66b2dfb40cd01ed5bf47e89943
IEDL.DBID RPM
ISSN 0189-6016
IngestDate Fri Sep 01 02:34:03 EDT 2023
Thu Apr 11 18:15:12 EDT 2024
Fri Aug 23 00:38:24 EDT 2024
Thu Nov 24 22:18:12 EST 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Myocardial infarction
Vitamin E-carnitine
ISO
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c267t-d97e4ec36ab995c4ae8a8d61efcdb37291423ae66b2dfb40cd01ed5bf47e89943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446450/
PMID 28573219
PQID 1905739054
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5446450
proquest_miscellaneous_1905739054
crossref_primary_10_21010_ajtcam_v14i2_4
pubmed_primary_28573219
PublicationCentury 2000
PublicationDate 2017-00-00
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017-00-00
PublicationDecade 2010
PublicationPlace Nigeria
PublicationPlace_xml – name: Nigeria
PublicationTitle African journal of traditional, complementary, and alternative medicines
PublicationTitleAlternate Afr J Tradit Complement Altern Med
PublicationYear 2017
Publisher African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
Publisher_xml – name: African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
References 1464372 - FASEB J. 1992 Dec;6(15):3379-86
11802770 - Biochem J. 2002 Feb 1;361(Pt 3):417-29
16106184 - Cardiol Rev. 2005 Sep-Oct;13(5):231-9
8800132 - J Am Coll Cardiol. 1996 Aug;28(2):506-14
6066618 - J Lab Clin Med. 1967 Jul;70(1):158-69
20685679 - Eur Heart J. 2010 Sep;31(18):2197-204
15086477 - Kidney Int. 2004 Apr;65(4):1375-80
26786992 - Acta Med Iran. 2015 Nov;53(11):703-10
26281314 - Turk J Med Sci. 2015;45(3):517-25
23406956 - Toxicol Ind Health. 2015 May;31(5):467-74
15591001 - Ann N Y Acad Sci. 2004 Nov;1033:30-41
8752197 - Am J Cardiol. 1996 Aug 15;78(4):477-9
10639540 - N Engl J Med. 2000 Jan 20;342(3):154-60
4436300 - J Biol Chem. 1974 Nov 25;249(22):7130-9
2756917 - Am J Clin Nutr. 1989 Aug;50(2):301-6
12401733 - Diabetes Care. 2002 Nov;25(11):1919-27
6123712 - Lancet. 1982 Jun 19;1(8286):1419-20
760819 - Biochim Biophys Acta. 1979 Jan 4;582(1):67-78
1678029 - Lancet. 1991 Apr 20;337(8747):933-5
2007906 - J Nutr. 1991 Apr;121(4):539-46
18203961 - Nutr Clin Pract. 2008 Feb;23(1):16-34
3532087 - Prev Med. 1986 Jul;15(4):373-90
References_xml
SSID ssj0038127
Score 2.1514022
Snippet The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by isoproterenol...
Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by...
BACKGROUNDThe current study aimed to evaluate the role of carnitine in combination with vitamin E in protection against myocardial infarction induced by...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 25
SubjectTerms Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Antioxidants - metabolism
Antioxidants - pharmacology
Antioxidants - therapeutic use
Cardiotonic Agents - adverse effects
Cardiotonic Agents - therapeutic use
Carnitine - pharmacology
Carnitine - therapeutic use
Glutathione Peroxidase - metabolism
Glutathione Reductase - metabolism
Heart - drug effects
Inflammation - blood
Inflammation - etiology
Inflammation - prevention & control
Isoproterenol - adverse effects
Male
Malondialdehyde - blood
Myocardial Infarction - chemically induced
Myocardial Infarction - metabolism
Myocardial Infarction - pathology
Myocardial Infarction - prevention & control
Myocardium - metabolism
Myocardium - pathology
Nitric Oxide - blood
Oxidative Stress - drug effects
Rats
Vitamin E - pharmacology
Vitamin E - therapeutic use
Title PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS
URI https://www.ncbi.nlm.nih.gov/pubmed/28573219
https://search.proquest.com/docview/1905739054
https://pubmed.ncbi.nlm.nih.gov/PMC5446450
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swELfaPkx7mfa97EuetIe9kACxwTwi4jSeGqgI6bq9IGMbNdNCqi3d37-zCVW7ve0FgWwsdL8Td-c7_w6hj7ZHkQ5I4MXMVx5JWOQlMW09o8G4xSyKEmLPDi_zaLEmny_p5RGiw1kYV7Svms24-7Edd5srV1t5vVWToU5scr7MKLH5OH9yjI5BQYcQvf_9ggXq-7QGLPEs10jP5wORTeBP5Pe9ktvx74BswrFtyRMyGk9DS7Nz1yr942r-XTF5xwTNH6NHB98Rp_03PkFHpnuKHiwP2fFnaHdeFhXPKnHBcVmccVzMcZaWuahEzvHqa87LU_GNz_AXUS3whajSpcgxx-lpCjF8hcWqcCuUPC_OsMhn6wwmwwozkWbwPE9LV3ICt7hMq9VztJ7zKlt4h4YKngqjeO_pJDbEqGkkmyShikjDJNNRYFqlG5u_C8C5kiaKmlC3DfGV9gOjadOS2EBcRqYv0Em368wrhMHNSmDIp37rExlS2epWMpC-tNTlLB6hT4NA6-ueN6OGeMPBUPcw1A6GmozQh0HgNei2TVjIzuxuftXgrAA8cIE5L3sAbhcbkBuh-B40txMsb_b9EVAnx599UJ_X__3mG_QwtNbd7cS8RSf7nzfmHfgm--a908U_yzDcJA
link.rule.ids 230,315,730,783,787,888,4031,27935,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb5swFLa6Ttp2Wfe7WdvNk3bYBQLE_DoiQhpvASriZO0uyBijZltItZEd9tfvGULVdqftgkA2Fuized_jPX8PofeqRlFpElNzPUNoxPcczXftSpMlGDfXcxyfqL3DceJMF-TjuX2-h-x-L0ybtC-KlV5_X-v16rLNrbxai2GfJzY8i0ObqHicMbyH7sN6NUjvpHcfYLBBXaVW0_M1pTbSKfqAb2MaQ_61EXyt_zLJytJVUR7Ls92RpYR2btqlv8jm3ZzJG0ZocoCW_eN3uSff9G1T6OL3HWXHf36_J-jxjpbioGt-ivZk_Qw9iHeB9-doc5alLAoZXUY4S2cRTic4DLKEMppEeH6RRNkp_RKN8WfKpnhJWRDTBEc4OA1oMmeYztN2hCxK0hmmyXgRQmcYYUyDEK4nQdZms8ApzgI2f4EWk4iFU21Xq0ETluM2Wum7kkgxcnjh-7YgXHrcKx1TVqIsVGjQBN7GpeMUVlkVxBClYcrSLiriSnD5yOgl2q83tTxEGBicD02GbVQG4ZbNq7LiHsDKlSq65w7Qhx6p_KqT5MjBlWnxzTt88xbfnAzQux7JHJaNioXwWm62P3PgQYA7HKDPqw7Z68H6KTFA7i3MrzsoSe7bLYBkK829Q-71f9_5Fj2csniWz2jy6Qg9shSJaH_4HKP95sdWngAFaoo37YT_AyxX_hY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELbarbTqpe9H-nSlHnqBADGvIyKwcZtARMh2dy_I2EbNbkOilvTQX98xhFV2e9sLAnmwZH2G-YYZvkHos-pRJExiaq5ncI34nqP5rl1pUoBzcz3H8Yn6d3iWOJMl-Xpmnx20-mqL9nm50uufa71e_WhrK7drPuzrxIbzWWgTlY8zhltRDe-jB_DMGk4fqHcvYfBDXbdW0_M1pTjSqfpAfGMaQ3bZcLbW_5hkZemqMY_l2e7IUmI7h77pP8J5u27ywBHFj9FFv4Su_uRK3zWlzv_eUne80xqfoEd7eoqDzuQpuifrZ-h4tk_AP0ebeZbmUZjT0whn6TTCaYzDIEtoTpMIL86TKDuhF9EYf6f5BJ_SPJjRBEc4OAlossgxXaTtDFmUpFNMk_EyBGOYYUyDEK7jIGurWuAUZ0G-eIGWcZSHE23fs0HjluM2mvBdSSQfOaz0fZsTJj3mCceUFRelShGawN-YdJzSElVJDC4MUwq7rIgrIfQjo5foqN7U8jXCwOR8GDJsozIIs2xWiYp5AC1T6uieO0BferSKbSfNUUBI02JcdBgXLcYFGaBPPZoFPD4qJ8Jqudn9LoAPAfZwAJtXHbrXk_XbYoDcG7hfGyhp7psjgGYr0b1H782d7_yIjufjuJjS5Ntb9NBSXKL97vMOHTW_dvI9MKGm_NDu-X9uPQCl
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PROTECTIVE+ROLE+OF+CARNITINE+SYNERGIZED+WITH+VITAMIN+E+AGAINST+ISOPROTERENOL+INDUCED+CARDIAC+INFARCTION+IN+RATS&rft.jtitle=African+journal+of+traditional%2C+complementary%2C+and+alternative+medicines&rft.au=Huwait%2C+Etimad+A.&rft.au=Al-Ghamdi%2C+Maryam+A.&rft.date=2017&rft.issn=0189-6016&rft.eissn=2505-0044&rft.volume=14&rft.issue=2&rft.spage=25&rft.epage=32&rft_id=info:doi/10.21010%2Fajtcam.v14i2.4&rft.externalDBID=n%2Fa&rft.externalDocID=10_21010_ajtcam_v14i2_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0189-6016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0189-6016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0189-6016&client=summon